Goldman Sachs’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.44M | Buy |
2,690,634
+1,415,319
| +111% | +$5.8M | ﹤0.01% | 3119 |
|
|
2025
Q4 | $4.3M | Buy |
1,275,315
+190,948
| +18% | +$496K | ﹤0.01% | 3885 |
|
|
2025
Q3 | $1.42M | Sell |
1,084,367
-360,363
| -25% | -$373K | ﹤0.01% | 4770 |
|
|
2025
Q2 | $1.04M | Sell |
1,444,730
-130,686
| -8% | -$103K | ﹤0.01% | 4669 |
|
|
2025
Q1 | $2.32M | Buy |
1,575,416
+660,144
| +72% | +$1.57M | ﹤0.01% | 4029 |
|
|
2024
Q4 | $4.05M | Sell |
915,272
-307,865
| -25% | -$1.25M | ﹤0.01% | 3660 |
|
|
2024
Q3 | $5.04M | Sell |
1,223,137
-340,295
| -22% | -$1.83M | ﹤0.01% | 3336 |
|
|
2024
Q2 | $10.2M | Buy |
1,563,432
+183,770
| +13% | +$1.3M | ﹤0.01% | 2484 |
|
|
2024
Q1 | $12M | Buy |
1,379,662
+297,997
| +28% | +$3.62M | ﹤0.01% | 2315 |
|
|
2023
Q4 | $12.4M | Sell |
1,081,665
-24,904
| -2% | -$246K | ﹤0.01% | 2332 |
|
|
2023
Q3 | $10.7M | Buy |
1,106,569
+112,105
| +11% | +$1.1M | ﹤0.01% | 2336 |
|
|
2023
Q2 | $10.6M | Sell |
994,464
-82,833
| -8% | -$890K | ﹤0.01% | 2398 |
|
|
2023
Q1 | $11.3M | Buy |
1,077,297
+59,169
| +6% | +$663K | ﹤0.01% | 2303 |
|
|
2022
Q4 | $12.6M | Sell |
1,018,128
-390,589
| -28% | -$4.43M | ﹤0.01% | 2372 |
|
|
2022
Q3 | $14.6M | Buy |
1,408,717
+416,590
| +42% | +$4.72M | ﹤0.01% | 2145 |
|
|
2022
Q2 | $11.4M | Sell |
992,127
-1,625,784
| -62% | -$19.2M | ﹤0.01% | 2387 |
|
|
2022
Q1 | $32.9M | Sell |
2,617,911
-693,230
| -21% | -$7.95M | 0.01% | 1649 |
|
|
2021
Q4 | $38.6M | Buy |
3,311,141
+235,865
| +8% | +$2.89M | 0.01% | 1554 |
|
|
2021
Q3 | $40.2M | Buy |
3,075,276
+43,705
| +1% | +$565K | 0.01% | 1450 |
|
|
2021
Q2 | $39M | Buy |
3,031,571
+1,450,335
| +92% | +$16.6M | 0.01% | 1476 |
|
|
2021
Q1 | $17.7M | Sell |
1,581,236
-581,872
| -27% | -$6.15M | ﹤0.01% | 2038 |
|
|
2020
Q4 | $24.6M | Buy |
2,163,108
+1,055,370
| +95% | +$11.5M | 0.01% | 1682 |
|
|
2020
Q3 | $9.96M | Sell |
1,107,738
-54,238
| -5% | -$539K | ﹤0.01% | 2327 |
|
|
2020
Q2 | $12M | Buy |
1,161,976
+388,915
| +50% | +$3.98M | ﹤0.01% | 2127 |
|
|
2020
Q1 | $7.8M | Sell |
773,061
-575,937
| -43% | -$6.77M | ﹤0.01% | 2278 |
|
|
2019
Q4 | $18M | Buy |
1,348,998
+316,575
| +31% | +$3.49M | ﹤0.01% | 1960 |
|
|
2019
Q3 | $8.86M | Buy |
1,032,423
+231,208
| +29% | +$2.25M | ﹤0.01% | 2410 |
|
|
2019
Q2 | $8.77M | Sell |
801,215
-1,234,362
| -61% | -$13.8M | ﹤0.01% | 2467 |
|
|
2019
Q1 | $23.1M | Buy |
2,035,577
+7,672
| +0.4% | +$85.7K | 0.01% | 1750 |
|
|
2018
Q4 | $17.6M | Buy |
2,027,905
+662,469
| +49% | +$7.6M | 0.01% | 1910 |
|
|
2018
Q3 | $21.1M | Buy |
1,365,436
+245,150
| +22% | +$3.88M | 0.01% | 1869 |
|
|
2018
Q2 | $17.9M | Buy |
1,120,286
+143,824
| +15% | +$2.13M | ﹤0.01% | 1960 |
|
|
2018
Q1 | $12.6M | Buy |
976,462
+439,205
| +82% | +$5.47M | ﹤0.01% | 2165 |
|
|
2017
Q4 | $6.75M | Buy |
537,257
+323,736
| +152% | +$4.23M | ﹤0.01% | 2755 |
|
|
2017
Q3 | $2.82M | Sell |
213,521
-739,837
| -78% | -$10.2M | ﹤0.01% | 3674 |
|
|
2017
Q2 | $15.1M | Sell |
953,358
-299,744
| -24% | -$4.36M | ﹤0.01% | 2186 |
|
|
2017
Q1 | $17.9M | Sell |
1,253,102
-71,692
| -5% | -$980K | ﹤0.01% | 1965 |
|
|
2016
Q4 | $17M | Sell |
1,324,794
-294,434
| -18% | -$3.72M | ﹤0.01% | 2076 |
|
|
2016
Q3 | $21.5M | Buy |
1,619,228
+1,179,344
| +268% | +$13.8M | 0.01% | 1830 |
|
|
2016
Q2 | $4.82M | Buy |
439,884
+212,697
| +94% | +$2.08M | ﹤0.01% | 2902 |
|
|
2016
Q1 | $2.08M | Buy |
227,187
+92,895
| +69% | +$766K | ﹤0.01% | 3429 |
|
|
2015
Q4 | $1.3M | Sell |
134,292
-67,082
| -33% | -$648K | ﹤0.01% | 4038 |
|
|
2015
Q3 | $1.76M | Sell |
201,374
-491,620
| -71% | -$4.59M | ﹤0.01% | 3927 |
|
|
2015
Q2 | $7M | Buy |
692,994
+263,033
| +61% | +$3.06M | ﹤0.01% | 2650 |
|
|
2015
Q1 | $5.76M | Sell |
429,961
-473,046
| -52% | -$6.21M | ﹤0.01% | 2763 |
|
|
2014
Q4 | $11.6M | Buy |
903,007
+442,602
| +96% | +$5.07M | ﹤0.01% | 2234 |
|
|
2014
Q3 | $5M | Sell |
460,405
-256,689
| -36% | -$2.94M | ﹤0.01% | 3020 |
|
|
2014
Q2 | $9.21M | Sell |
717,094
-11,715
| -2% | -$127K | ﹤0.01% | 2433 |
|
|
2014
Q1 | $7.52M | Buy |
728,809
+564,732
| +344% | +$6.35M | ﹤0.01% | 2616 |
|
|
2013
Q4 | $1.6M | Buy |
164,077
+99,927
| +156% | +$897K | ﹤0.01% | 4304 |
|
|
2013
Q3 | $636K | Sell |
64,150
-172,929
| -73% | -$1.7M | ﹤0.01% | 4973 |
|
|
2013
Q2 | $1.97M | Buy |
+237,079
| New | +$2.87M | ﹤0.01% | 3750 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Goldman Sachs's IRWD Position: Q1 2026 in Review
Goldman Sachs increased its Ironwood Pharmaceuticals (IRWD) stake by 111% in Q1 2026, buying an estimated $5.8M and bringing the position to 2,690,634 shares worth $9.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3119.
Goldman Sachs first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.2M in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Goldman Sachs held 2,690,634 shares of Ironwood Pharmaceuticals worth $9.44M as of Q1 2026.
- Goldman Sachs bought 1,415,319 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $5.8M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3119 holding.
- Goldman Sachs first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Ironwood Pharmaceuticals position peaked at $40.2M in Q3 2021.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.